Molecular Cytogenetics Market Size, Share & Trends Analysis Report 2023-2030 – A $4.46 billion by 2030, with CAGR of 10.6% from 2023 to 2030 – ResearchAndMarkets.com

Molecular Cytogenetics Market Size, Share & Trends Analysis Report 2023-2030 – A $4.46 billion by 2030, with CAGR of 10.6% from 2023 to 2030 – ResearchAndMarkets.com




Molecular Cytogenetics Market Size, Share & Trends Analysis Report 2023-2030 – A $4.46 billion by 2030, with CAGR of 10.6% from 2023 to 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Molecular Cytogenetics Market Size, Share & Trends Analysis Report By Application (Oncology, Personalized Medicine), By Technology (FISH, Immunohistochemistry, Karyotyping), By Product, By End-use, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s offering.


The global molecular cytogenetics market size is anticipated to reach USD 4.46 billion by 2030. The market is expected to expand at a CAGR of 10.6% from 2023 to 2030.

Rising penetration of molecular cytogenetics in clinical pathological testing, growing inclination towards targeted cancer treatment, and increasing focus on personalized medicine are the key factors driving growth. In addition, the increasing incidence of genetic disorders, technological advancements in the field of molecular cytogenetics, and rising R&D activities are anticipated to drive market expansion over the forecast period.

Furthermore, the cytogenetic analysis carried out through the integration of high throughput sequencers is another factor that is expected to significantly boost growth in the coming years. A number of scientists and researchers integrate NGS with cytogenetics laboratories as they are compliant with one another. Thus, with a significant drop in sequencing prices, the market is estimated to grow at a substantial pace.

The COVID-19 pandemic has positively impacted the market for molecular cytogenetics. Due to the shift in testing priorities, molecular cytogenetics laboratories were being redirected to conduct COVID-19 diagnostic testing. Furthermore, the increased focus on public health genomics has highlighted the value of molecular cytogenetics in population-based genomic surveillance and tracking disease spread, contributing to the development of effective public health strategies. Thus, the high incidence of diagnostic testing during the pandemic has fueled the growth of the market for molecular cytogenetics.

Increasing incidences of genetic disorders such as Down syndrome, Thalassemia, and Cystic Fibrosis are anticipated to fuel segment growth during the projected timeframe. For instance, according to WHO estimates, about 10 out of every 1000 people are affected with genetic disorders, which is approximately 70-80 million people globally. Moreover, rising strategic initiatives by operating players for technological advancements in cytogenetic tools are projected to propel the market for molecular cytogenetics. For instance, in October 2022, Genoox partnered with Thermo Fisher Scientific to introduce the CytoScan Automated Interpretation and Reporting (AIR) solution. This tool is expected to ease cytogenetic research data analysis.

Molecular Cytogenetics Market Report Highlights

  • Based on application, the oncology segment dominated the market with a share of 39.70% in 2022, due to the capability of the CGH technology to avail detailed studies for cancer etiology
  • Based on product, consumables dominated the segment with a share of 39.51% in 2022, owing to the increasing knowledge and awareness regarding genetic diseases and personalized medicines
  • Based on technology, the comparative genomic hybridization segment dominated the market for molecular cytogenetics in 2022 due to the rising technological advancements for better chromosomal analysis
  • Based on end-use, the clinical & research laboratories segment held a majority of the revenue share in 2022. On the other hand, the pharmaceutical & biotech companies segment is anticipated to witness the fastest CAGR over the forecast period
  • In 2022, North America dominated the industry owing to the rising technological advancements, improving healthcare infrastructure, the presence of major players, and the increasing number of drug trials and their approvals in the region

Key Attributes:

Report Attribute Details
No. of Pages 236
Forecast Period 2022 – 2030
Estimated Market Value (USD) in 2022 $2.02 Billion
Forecasted Market Value (USD) by 2030 $4.46 Billion
Compound Annual Growth Rate 10.6%
Regions Covered GlobalĀ 

Key Topics Covered:

Chapter 1 Molecular Cytogenetics Market: Research Methodology And Scope

Chapter 2 Molecular Cytogenetics Market: Executive Summary

Chapter 3 Molecular Cytogenetics Market: Market Variables, Trends & Scope

3.1 Market Lineage Outlook

3.1.1 Related/Ancillary Market Outlook

3.2 Market Dynamics

3.2.1 Market Drivers Analysis

3.2.1.1 Rapid technological advancements

3.2.1.2 Increasing prevalence of genetic disorders

3.2.1.3 Growing application in oncology

3.2.1.4 Increasing demand for personalized medicine

3.2.2 Market Restraint Analysis

3.2.2.1 High Costs Of Testing

3.2.2.2 Lack Of Reimbursement Policies

3.3 Industry Analysis Tools

Chapter 4 Molecular Cytogenetics Market: Application Business Analysis

4.1 Molecular Cytogenetics Market: Application Movement Analysis

4.2 Genetic Disorders

4.3 Oncology

4.4 Personalized Medicine

Chapter 5 Molecular Cytogenetics Market: Technology Business Analysis

5.1 Molecular Cytogenetics Market: Technology Movement Analysis

5.2 Comparative Genomic Hybridisation

5.2.2 ACGH

5.2.3 SCGH

5.3 Fish

5.4 Immunohistochemistry

5.5 Karyotyping

5.5.2 Spectral

5.5.3 Virtual

Chapter 6 Molecular Cytogenetics Market: Product Business Analysis

6.1 Molecular Cytogenetics Market: Product Movement Analysis

6.2 Instruments

6.3 Consumables

6.4 Software & Services

Chapter 7 Molecular Cytogenetics Market: End Use Business Analysis

7.1 Molecular Cytogenetics Market: End Use Movement Analysis

7.2 Clinical & Research Laboratories

7.3 Hospitals & Path Labs

7.4 Academic Research Institutes

7.5 Pharmaceutical & Biotech Companies

Chapter 8 Molecular Cytogenetics Market: Regional Business Analysis

Chapter 9 Molecular Cytogenetics Market: Competitive Landscape

9.1 Company Categorization

9.2 Strategy Mapping

9.3 Company Market Share Analysis, 2022

9.4 Company Profiles

  • Bioview
  • Danaher
  • Leica Biosystems Nussloch
  • Metasystems
  • Agilent Technologies
  • Abbott
  • Bio-Rad Laboratories
  • Illumina
  • Oxford Gene Technology
  • F. Hoffman-La Roche
  • Genentech
  • Perkinelmer
  • Quest Diagnostics
  • Sonora Quest Laboratories
  • Applied Spectral Imaging
  • Biological Industries USA
  • Cytotest
  • Cytognomix
  • Genial Genetics
  • Diagnostics Cytogenetics

For more information about this report visit https://www.researchandmarkets.com/r/vqcjt2

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900